Showing results (1031-1040 of 2,556) with videos related to

Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|July 8, 2021
Safety Profile of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney DiseaseIoannis Bellos
Therapeutics and Clinical Risk Management|July 8, 2021
Therapeutic Agents Rounding Up the Immunopathology of COVID-19Hong Peng Li, Xuan He, Liu Zhang, et al.
Therapeutics and Clinical Risk Management|October 16, 2020
Doxycycline Combined with NB-UVB Phototherapy for Acquired Reactive Perforating CollagenosisLimu Gao, Lixiong Gu, Zhen Chen, et al.
Therapeutics and Clinical Risk Management|July 29, 2021
Optimal Use of Perampanel in Asian Patients with Epilepsy: Expert OpinionYotin Chinvarun, Chin-Wei Huang, Ye Wu, et al.
Therapeutics and Clinical Risk Management|June 16, 2022
Cumulative Doses Predict the Risk of Furosemide-Induced Electrolyte Abnormalities in Critically Ill NeonatesKannan Sridharan, Abdulraoof Al Madhoob, Muna Al Jufairi
Therapeutics and Clinical Risk Management|May 27, 2021
Myocardial Injury After Temporary Transvenous Cardiac PacingMeng Liu, Pingsheng Wu
Therapeutics and Clinical Risk Management|June 3, 2008
Vaccination against hepatitis A in children: A review of the evidencePaolo Bonanni, Sara Boccalini, Angela Bechini
Therapeutics and Clinical Risk Management|June 3, 2008
Update on the treatment of disseminated fusariosis: Focus on voriconazoleMarta Stanzani, Fabio Tumietto, Nicola Vianelli, et al.
Therapeutics and Clinical Risk Management|June 3, 2008
Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infectionsMary L Townsend, Melanie W Pound, Richard H Drew
Pageof 256